Skip to main navigation Skip to search Skip to main content

Targeting neuromuscular junction to treat neuromuscular disorders

Research output: Contribution to journal › Review article › peer-review

29 Scopus citations

Abstract

The integrity and preservation of the neuromuscular junction (NMJ), the interface between the motor neuron and skeletal muscle, is critical for maintaining a healthy skeletal muscle. The structural and/or functional defects in the three cellular components of NMJ, namely the pre-synaptic terminal, synaptic cleft, and post-synaptic region, negatively affect skeletal muscle mass and/or strength. Therefore, NMJ repair appears to be an appropriate therapy for muscle disorders. Mouse models provide a detailed molecular characterization of various cellular components of NMJ with relevance to human diseases. This review discusses different molecular targets on the three cellular components of NMJ for treating muscle diseases. The potential effects of these therapies on NMJ morphology and motor performance, their therapeutic efficacy, and clinical relevance are discussed. Collectively, the available data supports targeting NMJ alone or as an adjunct therapy in treating muscle disorders. However, the potential impact of such interventions on human patients with muscle disorders requires further investigation.

Original languageEnglish
Article number122186
JournalLife Sciences
Volume333
DOIs
StatePublished - 15 Nov 2023

Keywords

  • Chronic obstructive pulmonary disease
  • Muscle wasting
  • Neuromuscular junction

Fingerprint

Dive into the research topics of 'Targeting neuromuscular junction to treat neuromuscular disorders'. Together they form a unique fingerprint.

Cite this